[HTML][HTML] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio… - Biology of Blood and …, 2015 - Elsevier
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …

[HTML][HTML] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio… - Biology of Blood and …, 2015 - astctjournal.org
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …

Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic …

M Koren-Michowitz, A Shimoni, F Daraio… - Biology of Blood and …, 2015 - europepmc.org
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …

[引用][C] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation …

M Koren Michowitz, A Shimoni, F Daraio… - BIOLOGY OF BLOOD …, 2015 - iris.unito.it
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular
Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid …

[PDF][PDF] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term PosteAllogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio, F Crasto… - Cell …, 2007 - cyberleninka.org
abstract Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic
myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current …

[PDF][PDF] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term PosteAllogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio, F Crasto… - academia.edu
abstract Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic
myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current …

[PDF][PDF] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term PosteAllogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio, F Crasto… - Cell Immunol, 2007 - core.ac.uk
abstract Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic
myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current …

Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic …

M Koren-Michowitz, A Shimoni… - Biology of blood …, 2015 - pubmed.ncbi.nlm.nih.gov
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …

Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation Chronic …

M Koren-Michowitz, A Shimoni, F Daraio… - Biology of Blood and …, 2015 - infona.pl
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …

[HTML][HTML] Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation …

M Koren-Michowitz, A Shimoni, F Daraio… - Biology of Blood and …, 2015 - tctjournal.org
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid
leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity …